The surgical Apgar score predicts postoperative complications and the survival in lung cancer patients

Purpose The surgical Apgar score (SAS)—calculated using the intraoperative variables estimated blood loss, lowest heart rate, and lowest mean systolic pressure—is associated with mortality in cancer surgery. We investigated the utility of the SAS in patients with lung cancer undergoing surgery. Methods We retrospectively analyzed the data of 691 patients who underwent surgery for primary lung cancer between 2015 and 2019 in a single institute and analyzed the impact of the SAS. Results Of the 691 patients, 138 (20%), 57 (8.2%), and 7 (1.0%) had postoperative complications of all grades, grades ≥ III, and grade V, respectively, according to the Clavien–Dindo classification. The C-index for postoperative complications of grades ≥ III was 0.605. A lower score (0–5 points) (odds ratio 3.09 against 8–10 points, P = 0.04) and a lower percentage of vital capacity (odds ratio 0.97, P = 0.04) were independent negative risk factors for major postoperative complications. Patients with a lower score (0–5 points) had poor 5-year overall and cancer-specific survival rates (60.1% and 72.3%, respectively; P < 0.05 for both). Conclusions The surgical Apgar score predicted postoperative complications and the long-term survival. Surgeons may improve surgical results using the SAS..

Medienart:

Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:53

Enthalten in:

Surgery today - 53(2023), 9 vom: 24. März, Seite 1019-1027

Sprache:

Englisch

Beteiligte Personen:

Hino, Haruaki [VerfasserIn]
Hagihira, Satoshi [VerfasserIn]
Maru, Natsumi [VerfasserIn]
Utsumi, Takahiro [VerfasserIn]
Matsui, Hiroshi [VerfasserIn]
Taniguchi, Yohei [VerfasserIn]
Saito, Tomohito [VerfasserIn]
Murakawa, Tomohiro [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

BKL:

44.00

Themen:

Lung cancer surgery
Postoperative outcomes
Prognostic marker
Surgical Apgar score

Anmerkungen:

© The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd. 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

doi:

10.1007/s00595-023-02677-x

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2145246274